
Bioretics is a Deep Tech company founded in 2012 specializing in Machine Vision solutions based on Machine Learning, combining biological inspiration with theoretical frameworks. The company develops highly optimized, industrial-grade AI-first projects focused on 2D, 2.5D, and 3D real-time image analysis from heterogeneous sources, primarily serving sectors like medicine, life sciences, industry, and public administration. Their flagship product, Aliquis®, enables no-code/low-code development and deployment of AI-based machine vision applications. Bioretics operates under the MLOpsDevOps paradigm, providing end-to-end systems from concept to market-ready devices, with a strong emphasis on environmental impact reduction and intellectual property protection. They collaborate with industrial partners worldwide, offering SaaS, on-premise products, AI-as-a-Service, consulting, and training, and have notable involvement in scientific programs such as the US BRAIN Initiative and the EU Human Brain Project.

Bioretics is a Deep Tech company founded in 2012 specializing in Machine Vision solutions based on Machine Learning, combining biological inspiration with theoretical frameworks. The company develops highly optimized, industrial-grade AI-first projects focused on 2D, 2.5D, and 3D real-time image analysis from heterogeneous sources, primarily serving sectors like medicine, life sciences, industry, and public administration. Their flagship product, Aliquis®, enables no-code/low-code development and deployment of AI-based machine vision applications. Bioretics operates under the MLOpsDevOps paradigm, providing end-to-end systems from concept to market-ready devices, with a strong emphasis on environmental impact reduction and intellectual property protection. They collaborate with industrial partners worldwide, offering SaaS, on-premise products, AI-as-a-Service, consulting, and training, and have notable involvement in scientific programs such as the US BRAIN Initiative and the EU Human Brain Project.